Earnings History Data for PLUS THERAPEUTICS, Inc. (PSTV) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
PLUS THERAPEUTICS, Inc.
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | PSTV | PLUS THERAPEUTICS, Inc. | 7.61 | -0.46 | -0.46 | 1.00 | Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M [11/14/2024 4:25 PM] |
1.16 | -0.10 (-7.94%) |
1.29 | 0.03 (2.38%) |
1.14 - 2.78 | 128,881 | 190,000 | 200 | ||
|
||||||||||||||||||
| 14-08-2024 | AH | PSTV | PLUS THERAPEUTICS, Inc. | 8.27 | -0.71 | 0.00 | -0.59 | Plus Therapeutics GAAP EPS of -$0.71 misses by $0.18, revenue of $1.27M beats by $0.15M [8/14/2024 4:50 PM] |
1.40 | -0.02 (-1.41%) |
1.45 | 0.03 (2.11%) |
0.97 - 3.21 | 28,781 | 70,000 | 600 | ||
| 15-05-2024 | AH | PSTV | PLUS THERAPEUTICS, Inc. | 9.24 | -0.75 | -0.25 | -31.47 | Plus Therapeutics GAAP EPS of -$0.75 beats by $0.34, revenue of $1.67M misses by $0.02M [5/15/2024 4:22 PM] |
2.18 | -0.14 (-6.03%) |
2.32 | 0.0 (0.00%) |
0.97 - 4.45 | 37,234 | 290,000 | 1,187 | ||
| 05-03-2024 | AH | PSTV | Plus Therapeutics | 9.00 | -0.70 | -0.78 | 0.00 | Plus Therapeutics GAAP EPS of -$4.24 misses by $3.07 [3/5/2024 4:09 PM] |
1.93 | -0.25 (-11.47%) |
2.30 | 0.12 (5.50%) |
0.97 - 5.24 | 70,567 | 30,000 | 7,888 | ||
| 31-10-2023 | AH | PSTV | PLUS THERAPEUTICS, Inc. | 3.11 | -1.00 | -0.58 | -42.71 | Plus Therapeutics GAAP EPS of -$1.00 beats by $0.18, revenue of $1.24M beats by $0.08M [10/31/2023 4:11 PM] |
1.27 | 0.05 (4.11%) |
1.36 | 0.14 (11.48%) |
0.97 - 7.50 | 710,391 | 210,000 | 500,378 | ||
| 14-08-2023 | AH | PSTV | PLUS THERAPEUTICS, Inc. | 7.88 | -0.59 | -1.91 | -53.95 | Plus Therapeutics GAAP EPS of -$0.59 beats by $1.44 [8/14/2023 4:07 PM] |
2.44 | -0.06 (-2.60%) |
2.31 | -0.19 (-7.60%) |
1.97 - 18.00 | 52,225 | 100,000 | 1,454 | ||
| 20-04-2023 | AH | 4:05 PM ET (Apr 20) |
PSTV | PLUS THERAPEUTICS, Inc. | 9.95 | -0.14 | -0.14 | -0.19 | Plus Therapeutics GAAP EPS of -$0.14 beats by $0.01 [4/20/2023 4:07 PM] |
0.2605 | -0.05 (-15.12%) |
0.29 | -0.02 (-6.39%) |
0.25 - 1.20 | 1,040,031 | 370,000 | 24,243 | |
| 23-02-2023 | AH | 4:05 PM ET (Feb 23) |
PSTV | PLUS THERAPEUTICS, Inc. | 12.15 | -0.16 | -0.15 | -0.27 | Plus Therapeutics GAAP EPS of -$0.77 misses by $0.02, revenue of $0.22M misses by $0.5M [2/23/2023 4:18 PM] |
0.3724 | -0.02 (-5.00%) |
0.37 | -0.02 (-5.36%) |
0.29 - 1.20 | 187,263 | 250,000 | 15,760 | |
| 20-10-2022 | AH | 4:05 PM ET (Oct 20) |
PSTV | PLUS THERAPEUTICS, Inc. | 11.32 | -0.19 | -0.21 | -0.28 | Plus Therapeutics GAAP EPS of -$0.19 beats by $0.02, revenue of $73K [10/20/2022 4:15 PM] |
0.4652 | -0.01 (-3.08%) |
0.48 | 0.0 (0.00%) |
0.39 - 2.16 | 264,464 | 2,640,000 | 4,067 | |
|
||||||||||||||||||
| 21-07-2022 | AH | 4:05 PM ET (Jul 21) |
PSTV | PLUS THERAPEUTICS, Inc. | 10.66 | -0.24 | -0.18 | -0.25 | Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02 [7/21/2022 4:11 PM] |
0.5351 | 0.03 (4.92%) |
0.54 | 0.03 (5.88%) |
0.39 - 2.60 | 126,246 | 70,000 | 14,715 | |
| 21-04-2022 | AH | 4:05 PM ET (Apr 21) |
PSTV | PLUS THERAPEUTICS, Inc. | 19.29 | -0.19 | -0.17 | -0.33 | Plus Therapeutics GAAP EPS of -$0.19 misses by $0.01 [4/21/2022 4:27 PM] |
0.7426 | -0.14 (-15.80%) |
0.88 | 0.0 (-0.23%) |
0.72 - 3.54 | 579,345 | 300,000 | 2,425 | |
| 24-02-2022 | AH | 4:05 PM ET (Feb 24) |
PSTV | PLUS THERAPEUTICS, Inc. | 21.39 | -0.27 | -0.23 | -0.73 | Plus Therapeutics GAAP EPS of -$1.11 misses by $0.01 [2/24/2022 4:55 PM] |
1.01 | 0.01 (0.50%) |
1.03 | 0.02 (1.98%) |
0.81 - 3.54 | 24,192 | 260,000 | 4,007 | |
| 21-10-2021 | AH | 4:05 PM ET (Oct 21) |
PSTV | PLUS THERAPEUTICS, Inc. | 26.18 | -0.28 | -0.21 | -0.39 | Plus Therapeutics EPS misses by $0.04 [10/21/2021 4:28 PM] |
1.66 | -0.07 (-4.05%) |
1.70 | -0.03 (-1.73%) |
1.59 - 5.42 | 334,488 | 210,000 | 12,805 | |
| 22-07-2021 | AH | 4:05 PM ET (Jul 22) |
PSTV | PLUS THERAPEUTICS, Inc. | 22.93 | -0.25 | -0.23 | -0.45 | Plus Therapeutics EPS misses by $0.01 [7/22/2021 4:08 PM] |
2.17 | -0.11 (-4.82%) |
2.21 | -0.07 (-3.07%) |
1.92 - 5.42 | 206,475 | 380,000 | 10,486 | |
|
||||||||||||||||||
| 22-04-2021 | AH | 4:05 PM ET (Apr 22) |
PSTV | PLUS THERAPEUTICS, Inc. | 18.90 | -0.33 | -0.31 | -0.28 | Plus Therapeutics EPS beats by $0.03 [4/22/2021 4:15 PM] |
2.38 | 0.15 (6.47%) |
2.45 | 0.21 (9.38%) |
1.40 - 5.42 | 373,863 | 400,000 | 34,793 | |
| 22-02-2021 | AH | 4:05 PM ET (Feb 22) |
PSTV | PLUS THERAPEUTICS, Inc. | 16.20 | -0.73 | -0.33 | 0.12 | Plus Therapeutics EPS misses by $1.46 [2/22/2021 4:13 PM] |
3.12 | -0.63 (-16.81%) |
3.32 | -0.43 (-11.47%) |
0.93 - 5.42 | 1,122,321 | 2,913,124 | 76,974 | |
| 22-10-2020 | AH | After the close (Oct 22) |
PSTV | PLUS THERAPEUTICS, Inc. | 12.17 | -0.39 | 0.00 | -0.03 | Plus Therapeutics EPS beats by $0.16 [10/22/2020 4:11 PM] |
2.58 | -0.18 (-6.52%) |
2.68 | -0.08 (-2.90%) |
0.93 - 3.56 | 121,279 | 122,805 | 1,576 | |
|
|
||||||||||||||||||